Drug recall · October 10, 2018
robaxin-750 recall
Why: Labeling: Incorrect Instructions: Dosage information on the immediate container label incorrectly states "Two to four tablets four times daily." rather than the correct dosage of "Two tablets three times daily."
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
robaxin-750 (methocarbamol tablets, USP), 750 mg, 100-count bottle, Rx Only, Distributed by: Endo Pharmaceuticals Inc., Malvern, PA 19355; Manufactured by: Kremers Urban Pharmaceuticals Inc., a subsidiary of Lannett Company, Inc., Seymour, IN 47274; NDC 52244-449-10.
- Lots / codes
Lot #: 216702P1, Exp 09/20; 220409P1, Exp 01/21
- Quantity
- 2,856 bottles
- Company
- Endo Pharmaceuticals, Inc., Malvern, PA
- Distribution
- Nationwide in the USA.
- Initiated
- September 17, 2018 · Voluntary: Firm initiated
- Classified
- October 9, 2018
- Reported
- October 10, 2018
- Ended
- February 4, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Methocarbamol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.